Not long ago, Chinese State Food and Drug Administration has approved the production of human bird flu vaccine, allowing industrial test and authority approval at the same time. The vaccine, jointly developed by Beijing Kexing Bioproducts and China Diseases Prevention and Control Center, is designed for the age groups from 18 to 60. The new vaccine has been approved on April 2008 by the State Food and Drug Administration for drug registration. The administrative efforts have made China ready for bird flu vaccine production and storage, allowing the government to use them when pandemics is on the way.